AXID Drug Patent Profile

✉ Email this page to a colleague

Axid is a drug marketed by Smithkline Beecham, Braintree, and Haleon Us Holdings. and is included in three NDAs.

The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nizatidine profile page.

A generic version of AXID was approved as nizatidine by EPIC PHARMA LLC on July 5^th, 2002.

US Patents:	0
Applicants:	3
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	82
Patent Applications:	4,807
DailyMed Link:	AXID at DailyMed

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
AXID	Oral Solution	nizatidine	15 mg/mL	021494	1	2008-05-14

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-001	Apr 12, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Haleon Us Holdings	AXID AR	nizatidine	TABLET;ORAL	020555-001	May 9, 1996		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-002	Apr 12, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Braintree	AXID	nizatidine	SOLUTION;ORAL	021494-001	May 25, 2004		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-001	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-002	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
Braintree	AXID	nizatidine	SOLUTION;ORAL	021494-001	May 25, 2004	⤷ Sign Up	⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-002	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-002	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-001	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
Smithkline Beecham	AXID	nizatidine	CAPSULE;ORAL	019508-001	Apr 12, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

See the table below for patents covering AXID around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Poland	233295		⤷ Sign Up
Israel	63980	N-THIAZOL-4-YLMETHYLTHIOALKYL DERIVATIVES USED AS ANTIULCER AGENTS AND PROCESS FOR THEIR PREPARATION	⤷ Sign Up
Luxembourg	88293		⤷ Sign Up
German Democratic Republic	200371	VERFAHREN ZUR HERSTELLUNG VON 2,4-DISUBSTITUIERTEN THIAZOLEN	⤷ Sign Up
Spain	8301950		⤷ Sign Up
Germany	3171819		⤷ Sign Up
South Korea	830007602		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration